ZEISS Launches ALTA DUO 300 to Expand Retinal Imaging Portfolio
Event summary
- ZEISS introduced the ALTA DUO 300, a fully automated, multimodal retinal imaging device combining OCT and fundus photography.
- The device will be showcased at the EURETINA congress in Vienna from October 1–4, 2026, and available in select markets later in 2026.
- ZEISS ALTA DUO 300 integrates four key diagnostic technologies, including AI-enhanced OCT-Angiography and full chamber depth anterior OCT.
- The device complements ZEISS's existing CIRRUS solution, expanding its retinal imaging portfolio for diverse eye care practices.
The big picture
ZEISS's launch of the ALTA DUO 300 underscores the growing demand for efficient, multimodal retinal imaging solutions. The device's automated capabilities and integration of multiple diagnostic functionalities align with broader industry trends toward streamlined workflows and enhanced diagnostic accuracy. With revenue of €2.228 billion in fiscal year 2024/25, ZEISS is positioning itself to capture a larger share of the retinal imaging market, particularly in practices seeking cost-effective and versatile solutions.
What we're watching
- Market Adoption
- The pace at which the ALTA DUO 300 gains traction in eye care practices, particularly those with varying clinical priorities and workflow requirements.
- Competitive Positioning
- Whether ZEISS can sustain its leadership in retinal imaging against competitors with similar multimodal solutions.
- Regulatory Approvals
- The timeline for regulatory approvals in key markets, which will determine the device's global availability and revenue potential.
Related topics